Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 21 for “"CSPG4"”.

  1. CSPG4 in osteosarcoma: functional roles and therapeutic potential

    … representing a large unmet clinical need. CSPG4 is a transmembrane protein which is expressed on a number of progenitor cells and tumour types. Preliminary work had found CSPG4 present in osteosarcoma tumour samples. In this study, CSPG4 mRNA and protein expression was demonstrated in …

    edinburgh Repository record for CSPG4 in osteosarcoma: functional roles and therapeutic potential (opens in a new tab)

  2. Expression and function of NG2/CSPG4 in human chondrocytes

    INTRODUCTION: NG2/CSPG4 is a unique transmembrane chondroitin sulphate proteoglycan molecule expressed as a core protein and a chondroitin sulphate proteoglycan (CSPG) up to 400kD. NG2/CSPG4 mediates the communication between the extracellular and intracellular compartments through interactions …

    edinburgh Repository record for Expression and function of NG2/CSPG4 in human chondrocytes (opens in a new tab)

  3. Molecular mechanisms regulating gene expression and signalling dependence of CSPG4 in melanoma

    … Chondroitin Sulfate Proteoglycan 4 (CSPG4) is a cell surface type I transmembrane protein associated with the progression of several cancers including melanoma, triple-negative breast cancer, gliomas, oligodendrocytomas and squamous cell carcinoma. In particular, CSPG4 is highly …

    kings Repository record for Molecular mechanisms regulating gene expression and signalling dependence of CSPG4 in melanoma (opens in a new tab) Download PDF for Molecular mechanisms regulating gene expression and signalling dependence of CSPG4 in melanoma (opens in a new tab)

  4. Cspg4 as a potential target of antibody-based immunotherapy for malignant mesothelioma

    … disease. Chondroitin Sulfate Proteoglycan 4 (CSPG4) is a cell surface proteoglycan that is highly expressed and involved in cell proliferation and migration of many tumor cell types [2]. Through binding this antigen with extracellular matrix components (ECM) components (such as Collagens and …

    hawaii Repository record for Cspg4 as a potential target of antibody-based immunotherapy for malignant mesothelioma (opens in a new tab)

  5. Targeted cerium oxide nanoparticles for investigating CSPG4 interactions with the basement membrane

    … tissues. Cancers expressing the melanoma marker, CSPG4, are typically highly aggressive and difficult to treat. CSPG4 is known to bind to some BM components, and has been identified as a potential immunotherapeutic target. Elevated levels of intracellular reactive oxygen species (ROS) are also one …

    unsw Repository record for Targeted cerium oxide nanoparticles for investigating CSPG4 interactions with the basement membrane (opens in a new tab)

  6. The Roles of CSPG4 and Perlecan in Cancer, Potential Targets for Drug Therapy

    … studies have shown that the proteoglycans CSPG4 and perlecan, are able to mediate some of these cell-ECM interactions, identifying them as potential immunotherapeutic targets to control cancer spread. However, studies on both of these molecules have shown different results when cancer cells …

    unsw Repository record for The Roles of CSPG4 and Perlecan in Cancer, Potential Targets for Drug Therapy (opens in a new tab)

  7. Development of Novel Antibody-Based Immunotherapies Targeting Human Chondroitin Sulfate Proteoglycan 4

    <p>Chondroitin sulfate proteoglycan 4 (CSPG4) is a promising target for cancer immunotherapy due to its high level of expression in a number of malignant tumors, and its essential role in tumor growth and progression. Clinical application of CSPG4-targeting immunotherapies is hampered by the lack …

    duke Repository record for Development of Novel Antibody-Based Immunotherapies Targeting Human Chondroitin Sulfate Proteoglycan 4 (opens in a new tab)

  8. Investigation of the role of chondroitin sulfate proteoglycan in causing treatment resistance in melanoma to PI3k/mTOR inhibition.

    … a challenge. Chondroitin sulfate proteoglycan (CSPG4) is expressed on the surface of melanoma cells, and its role in metastatic progression has been established. One known mechanism responsible for this activity is modulation of the activity of ERK1,2. PI3k/mTOR pathway is also frequently …

    umn Repository record for Investigation of the role of chondroitin sulfate proteoglycan in causing treatment resistance in melanoma to PI3k/mTOR inhibition. (opens in a new tab)

  9. THE ROLE OF ABCA8 IN THE BRAIN

    … in part by interacting with and modulating CSPG4, a protein essential for oligodendrocyte precursor cell (OPC) proliferation, migration, and myelination. The absence of Abca8b, a mouse ortholog of ABCA8, led to reduced levels of cerebellar myelin, as well as Cnp, Plp1, and Mog, all essential …

    nus Repository record for THE ROLE OF ABCA8 IN THE BRAIN (opens in a new tab) Download file for THE ROLE OF ABCA8 IN THE BRAIN (opens in a new tab)

  10. Structural Analysis of Clostridium Difficile Tcbd Uptake Mechanism

    … (FZD2) and chondroitin sulfate proteoglycan 4 (CSPG4), using cryo-EM and biochemical assays. TcdB utilizes hydrophobic interactions to bind FZD2 and CSPG4, and CSPG4 also has electric charge interactions with TcdB. Three snapshots of TcdB binding to CSPG4 were obtained, demonstrating that TcdB …

    tamu Repository record for Structural Analysis of Clostridium Difficile Tcbd Uptake Mechanism (opens in a new tab)

  11. Dissecting humoral immune responses in melanoma and the design of antibody immunotherapy

    … IgG4) against the tumour-associated antigen CSPG4 were engineered to examine the functional significance of IgG4 subclass. Despite ac-cumulation in tumours, anti-CSPG4 IgG4, in contrast to anti-CSPG4 IgG1, did not trigger effector cells to kill tumours in vitro and in vivo. IgG4 mediated IgG1 …

    kings Repository record for Dissecting humoral immune responses in melanoma and the design of antibody immunotherapy (opens in a new tab) Download PDF for Dissecting humoral immune responses in melanoma and the design of antibody immunotherapy (opens in a new tab)

  12. Radiolabelling and biodistribution of IgE antibodies

    … Objectives: The aim was to radiolabel both anti-CSPG4-IgE and MOV18-IgE, and their IgG counterparts targeted to the same antigen, while maintaining the functionality of the antibodies; and subsequently, to compare IgE with IgG in in vivo imaging and biodistribution studies in a disease model. …

    kings Repository record for Radiolabelling and biodistribution of IgE antibodies (opens in a new tab) Download PDF for Radiolabelling and biodistribution of IgE antibodies (opens in a new tab)

  13. Clostridium difficile Toxins: Entry and Uptake

    … receptors, Chondroitin Sulfate Proteoglycan 4 (CSPG4). Using a series of truncations, we showed that TcdB required only three short CROP repeats for CSPG4 binding, resolving some contradictory data regarding the role of CROP domain in the field. Overall, the results of these studies provide …

    toronto-retro Repository record for Clostridium difficile Toxins: Entry and Uptake (opens in a new tab)

  14. Molecular role of Kon-tiki during myotube migration and attachment

    … providing insights to how Kon homologues, NG2/CSPG4, may increase the metastatic potential of melanomas or of soft tissue sarcoma.

    lmu-germany Repository record for Molecular role of Kon-tiki during myotube migration and attachment (opens in a new tab)

  15. Exploring the role of mesenchymal progenitors in the medulloblastoma tumor microenvironment

    … markers, such as Pdgfrb, Rgs5 and Cspg4. The proliferation rate of tumor-associated MPs was markedly increased compared to cerebellar MPs, indicative of their activation in the MB TME. Single-cell RNA sequencing showed that tumor-associated MPs displayed an altered transcriptomic …

    ubc Repository record for Exploring the role of mesenchymal progenitors in the medulloblastoma tumor microenvironment (opens in a new tab) Download PDF for Exploring the role of mesenchymal progenitors in the medulloblastoma tumor microenvironment (opens in a new tab)

  16. Development of potential immunodiagnostic & therapeutic techniques using SNAP-fusion proteins as tools for the validation of Triple-negative Breast Cancer

    … the following tumour associated antigens (TAAs): CSPG4 (a transmembrane protein found in 50% of TNBC cases), EGFR (which is overexpressed in 13-76% of TNBCs), and MSLN (which is overexpressed in 67% of TNBCs) as potential targets for monospecific therapy. The evolution of antibody-based …

    cape-town Repository record for Development of potential immunodiagnostic & therapeutic techniques using SNAP-fusion proteins as tools for the validation of Triple-negative Breast Cancer (opens in a new tab)

  17. Cancer Evolution under Chemotherapy Treatment

    … The spheroids had high ability of invasion. The CSPG4 protein was found to play an important role to spheroid formation and invasion. RNA-sequencing showed that EOC cells altered the gene profile in mesothelial cells at spheroid formation and induced more aggressive characteristics. Finally, in …

    lund Repository record for Cancer Evolution under Chemotherapy Treatment (opens in a new tab) Download file for Cancer Evolution under Chemotherapy Treatment (opens in a new tab)

  18. Η επίδραση των νευροστεροϊδών στο κεντρικό νευρικό σύστημα και το αντίκτυπο στην απομυελίνωση

    … spatial correlation with the gene expression of Cspg4, Pdgfra, L1cam, Ncam1, Ncam2 and Ptprz1. Spatially correlated genes are mainly expressed by mature oligodendrocytes (like Cntn2), while spatially anticorrelated genes are mainly expressed by oligodendrocyte precursor cells. According to the …

    greece Repository record for Η επίδραση των νευροστεροϊδών στο κεντρικό νευρικό σύστημα και το αντίκτυπο στην απομυελίνωση (opens in a new tab)

Page 1 of 2